Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ZYMEWORKS INC.

(ZYME)
  Report
Real-time Estimate Cboe BZX  -  02:19 2022-09-26 pm EDT
5.370 USD   +1.90%
09/22Zymeworks : Shareholder Director Nominations - Form 8-K
PU
09/22Zymeworks Inc. : Other Events (form 8-K)
AQ
09/16Zymeworks Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

ZYMEWORKS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

10/26/2021 | 04:18pm EDT

ITEM 7.01 REGULATION FD DISCLOSURE

On October 26, 2021, Zymeworks Inc. ("Zymeworks") issued a press release announcing that management will host a conference call and webcast to provide details related to the launch of its Phase 3 first-line gastroesophageal adenocarcinoma (GEA) pivotal study, HERIZON-GEA-01, and to discuss the commercial potential of zanidatamab in gastrointestinal cancers.

On October 26, 2021, Zymeworks filed this press release with the Canadian securities regulatory authorities on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com. A copy of this press release is attached as Exhibit 99.1 hereto.

The information provided under this Item (including Exhibit 99.1, attached hereto) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS


(d) Exhibits



Exhibit No.       Description

99.1                Press Release dated October 26, 2021.

104               Cover Page Interactive Data File (embedded as Inline XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about ZYMEWORKS INC.
09/22Zymeworks : Shareholder Director Nominations - Form 8-K
PU
09/22Zymeworks Inc. : Other Events (form 8-K)
AQ
09/16Zymeworks Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
09/16Zymeworks Says Proxy Advisory Firm Glass Lewis Recommends Approval of Redomicile Plans
MT
09/16Independent Proxy Advisory Firm Glass Lewis Recommends Zymeworks Shareholders Vote FOR ..
BU
09/14Transcript : Zymeworks Inc. Presents at Morgan Stanley 20th Annual Global Hea..
CI
09/13Citigroup Lowers Zymeworks Price Target to $21 From $27, Maintains Buy Rating
MT
09/12Zymeworks Presents Early-Stage Results for Prospective Cancer Therapy
MT
09/12Zymeworks Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
09/12Transcript : Zymeworks Inc. - Special Call
CI
More news
Analyst Recommendations on ZYMEWORKS INC.
More recommendations